6-phosphogluconate dehydrogenase
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
<StructureSection load='1pgo' size='400' side='right' caption='Sheep 6-phosphogluconate dehydrogenase complex with cofactor NADP and sulfate (PDB code [[1pgo]])' scene='49/491981/Cv/2'> | <StructureSection load='1pgo' size='400' side='right' caption='Sheep 6-phosphogluconate dehydrogenase complex with cofactor NADP and sulfate (PDB code [[1pgo]])' scene='49/491981/Cv/2'> | ||
==Introduction== | ==Introduction== | ||
- | '''6-phosphogluconate dehydrogenase''' or '''imine reductase''' (6PGD) is an enzyme that plays a key role in the pentose phosphate pathway (PPP), also known as the phosphogluconate pathway. The PPP is a metabolic pathway that operates alongside glycolysis and is involved in the production of NADPH (nicotinamide adenine dinucleotide phosphate) and ribose-5-phosphate, which are essential for various cellular processes. | + | '''6-phosphogluconate dehydrogenase''' or '''imine reductase''' (it's NAD-binding domain) (6PGD) is an enzyme that plays a key role in the pentose phosphate pathway (PPP), also known as the phosphogluconate pathway. The PPP is a metabolic pathway that operates alongside glycolysis and is involved in the production of NADPH (nicotinamide adenine dinucleotide phosphate) and ribose-5-phosphate, which are essential for various cellular processes. |
6PGD catalyzes the oxidative decarboxylation of 6-phosphogluconate to produce ribulose-5-phosphate and NADPH. The reaction also releases carbon dioxide (CO2). This step in the pathway is critical for generating NADPH, which serves as a reducing agent for various biosynthetic reactions, including fatty acid and cholesterol synthesis, as well as maintaining cellular redox balance. | 6PGD catalyzes the oxidative decarboxylation of 6-phosphogluconate to produce ribulose-5-phosphate and NADPH. The reaction also releases carbon dioxide (CO2). This step in the pathway is critical for generating NADPH, which serves as a reducing agent for various biosynthetic reactions, including fatty acid and cholesterol synthesis, as well as maintaining cellular redox balance. |
Current revision
|
References
- ↑ Beam TR Jr. Quinolone therapy in intensive care unit settings. New Horiz. 1993 May;1(2):187-93. PMID:7922402
- ↑ Monga A, Makkar RP, Arora A, Mukhopadhyay S, Gupta AK. Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency. Can J Infect Dis. 2003 Jul;14(4):230-1. PMID:18159462